| Literature DB >> 16135762 |
Shih-Chieh Chuang1, Wangfa Zhao, Robert Bauchwitz, Qijiang Yan, Riccardo Bianchi, Robert K S Wong.
Abstract
Mutations in FMR1, which encodes the fragile X mental retardation protein (FMRP), are the cause of fragile X syndrome (FXS), an X-linked mental retardation disorder. Inactivation of the mouse gene Fmr1 confers a number of FXS-like phenotypes including an enhanced susceptibility to epileptogenesis during development. We find that in a FXS mouse model, in which the function of FMRP is suppressed, synaptically released glutamate induced prolonged epileptiform discharges resulting from enhanced group I metabotropic glutamate receptor (mGluR)-mediated responses in hippocampal slices. The induction of the group I mGluR-mediated, prolonged epileptiform discharges was inhibited in preparations that were pretreated with inhibitors of ERK1/2 (extracellular signal-regulated kinase 1/2) phosphorylation or of mRNA translation, and their maintenance was suppressed by group I mGluR antagonists. The results suggest that FMRP plays a key role in the control of signaling at the recurrent glutamatergic synapses in the hippocampus. The absence of this control causes the synaptically activated group I mGluRs to elicit translation-dependent epileptogenic activities.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16135762 PMCID: PMC6725444 DOI: 10.1523/JNEUROSCI.1777-05.2005
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167